TransMedics Group, Inc. TMDX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 59.1%-0.4pp | 59.9%+0.6pp | 60.3%+0.9pp | 59.8%-0.9pp | 59.5%-2.9pp | |
| Operating margin | 14.9%+4.1pp | 17.9%+9.4pp | 16.9%+9.7pp | 14.4%+15.4pp | 10.8%+16.4pp | |
| Net margin | 27%— | 31.4%— | 16.2%— | —— | —— | |
| EBITDA margin | 20%+4.8pp | 22.4%+9.5pp | 21.4%+9.8pp | 18.9%+15.8pp | 15.2%+17.1pp | |
| Returns | ||||||
| Return on equity | 45.2%— | 54.2%— | 32.5%— | —— | —— | |
| Return on assets | 15.1%— | 20.3%— | 10.6%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.6×-0.1× | 0.6×+0.1× | 0.7×+0.1× | 0.6×+0.1× | 0.6×0.0× | |
| Inventory turnover | 5.6×+1.3× | 5.1×+1.1× | 4.7×+1.1× | 4.9×+1.3× | 4.3×+1.2× | |
| Liquidity | ||||||
| Current ratio | 6.7×-2.4× | 7.1×-1.2× | 7.7×-0.5× | 9.9×+0.5× | 9.1×-0.6× | |
| Quick ratio | 6.2×-2.1× | 6.6×-0.9× | 7.1×-0.2× | 9.2×+0.7× | 8.3×-0.4× | |
| Cash ratio | 5×-0.6× | 5.5×-0.2× | 5.8×+0.4× | 7.1×+0.4× | 5.6×-1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.6× | 0.1×-0.2× | 0.2×-0.1× | 0.2×-0.1× | 0.3×-0.2× | |
| Debt-to-assets | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -0.4×+2.9× | -3.1×— | -3.3×— | -3.3×— | -3.3×— | |
| Interest coverage | 5.4×+1.7× | 7.9×+5.3× | 6.9×+4.9× | 5.4×+5.7× | 3.7×+4.9× | |
| Per Share | ||||||
| Book value per share | $13.65+105% | $11.67+79.8% | $8.72+48.2% | $7.84+45.7% | $6.67+45.1% | |
| Valuation | ||||||
| Market capitalization | $3.41B+50.6% | $4.16B+98.7% | $3.82B-27.1% | $4.49B-10.0% | $2.26B-6.5% | |
| Enterprise value | $3.36B+66.0% | $3.74B+105% | $3.43B-31.3% | $4.15B-11.5% | $2.02B-5.5% | |
| Price / earnings | 19.8×— | 21.8×— | 41.7×— | —— | —— | |
| Price / sales | 5.4×+0.7× | 6.9×+2.1× | 6.8×-6.3× | 8.4×-5.5× | 4.6×-3.5× | |
| Price / book | 6.9×-1.6× | 8.8×-0.4× | 10.8×-14.2× | 14.1×-12.2× | 8.5×-6.7× | |
| EV / EBITDA | 26.4×-0.9× | 27.5×— | 28.2×— | 41.4×— | 27.3×— | |
| EV / sales | 5.3×+1.1× | 6.2×+2.0× | 6×-6.4× | 7.8×-5.3× | 4.1×-3.1× | |
| Earnings yield | 5%— | 4.6%— | 2.4%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TransMedics Group, Inc.'s profit margins?
- TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
- Where do TransMedics Group, Inc.'s ratios come from?
- Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
